This editorial discusses a study evaluating the efficacy of tegoprazan, a novel potassium-competitive acid blocker (P-CAB), compared to esomeprazole for improving nighttime GERD symptoms and sleep disturbances. The study found that tegoprazan showed faster improvement in nighttime heartburn compared to esomeprazole, suggesting it may be a more effective treatment option for nighttime reflux.
Publisher
Journal of Neurogastroenterology and Motility
Published On
Jan 01, 2023
Authors
Yonghoon Choi, Cheol Min Shin
Tags
tegoprazan
potassium-competitive acid blocker
GERD
nighttime symptoms
esomeprazole
sleep disturbances
treatment efficacy
Related Publications
Explore these studies to deepen your understanding of the subject.